Human bone marrow niche organoids for disease modeling and therapeutic application in hematopoietic syndrome
Biomaterials · 2026
DOI: 10.1016/j.biomaterials.2025.123744 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials, 2026. Verfasst von Heebin Park und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biohealth Convergence, College of Science and Convergence Technology, Seoul Women's University, Seoul, 01797, Republic of Korea. Hauptthemen laut MEDLINE: Organoids, Bone Marrow, Acute Radiation Syndrome, Stem Cell Niche. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Seoul Women's University, National Research Foundation of Korea, Korea Institute of Radiological and Medical Sciences.
Abstract (Originalsprache)
Hematopoietic acute radiation syndrome (H-ARS) is a serious clinical condition caused by exposure to high-dose ionizing radiation that leads to the depletion of hematopoietic stem and progenitor cells with the collapse of the function of bone marrow. Despite the clinical significance of H-ARS, there have been few advances in H-ARS research owing to the dearth of physiologically relevant human models that mimic the complex bone marrow microenvironment. In this study, we used a stage-specific mesodermal differentiation protocol to establish human bone marrow organoids (hBMOs) derived from hiPSCs. The resulting organoids exhibited stromal-vascular architecture, supported multilineage hematopoiesis, and contained CD34+ hematopoietic populations, as confirmed by scRNA-seq and flow cytometry. To investigate the impact on the hematopoietic cell population, hBMOs were exposed to γ-irradiation at doses of 3, 6, and 9 Gy. The organoids exhibited a marked depletion of hematopoietic cell populations and disruption of niche architecture, which are hallmarks of radiation-induced hematopoietic cell damage. To evaluate the therapeutic potential of hBMOs in H-ARS, hBMOs transplanted into lethally irradiated NSG mice significantly improved survival with successful engraftment of human hematopoietic cells within the host. These findings establish hBMOs as a robust and translational human model of radiation-induced hematopoietic cell damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biohealth Convergence, College of Science and Convergence Technology, Seoul Women's University, Seoul, 01797, Republic of Korea.
- Division of Radiation Biomedical Research, Korea Institute of Radiological & Medical Sciences, Seoul, 01812, Republic of Korea.
- Research Center, HLB BioStep Co., Ltd., Incheon, 22014, Republic of Korea.
- Division of Radiation Biomedical Research, Korea Institute of Radiological & Medical Sciences, Seoul, 01812, Republic of Korea. Electronic address: spchoi@kirams.re.kr.
- Department of Biohealth Convergence, College of Science and Convergence Technology, Seoul Women's University, Seoul, 01797, Republic of Korea. Electronic address: jmj1103@swu.ac.kr.
Förderung
- Seoul Women's University
- National Research Foundation of Korea
- Korea Institute of Radiological and Medical Sciences
- Korea Ministry of Science and ICT
- Ministry of Education
Zitieren
APA
Park, H., Yu, I., Kim, T. J., Jang, H., Kim, H. B., Lee, S. B., Yoo, K., Shim, S., Choi, S. P., & Jeong, J. (2026). Human bone marrow niche organoids for disease modeling and therapeutic application in hematopoietic syndrome. Biomaterials. https://doi.org/10.1016/j.biomaterials.2025.123744
Vancouver
Park H, Yu I, Kim TJ, Jang H, Kim HB, Lee SB, et al. Human bone marrow niche organoids for disease modeling and therapeutic application in hematopoietic syndrome. Biomaterials. 2026. doi:10.1016/j.biomaterials.2025.123744
BibTeX
@article{Park2026,
author = {Park, Heebin and Yu, Inseon and Kim, Tae-Jin and Jang, Hyosun and Kim, Han Byul and Lee, Seung Bum and Yoo, Kichun and Shim, Sehwan and Choi, Sang-Pil and Jeong, Jaemin},
title = {Human bone marrow niche organoids for disease modeling and therapeutic application in hematopoietic syndrome},
journal = {Biomaterials},
year = {2026},
doi = {10.1016/j.biomaterials.2025.123744}
}
EUVIMED